Table 1.
Ranking | Organizations | Lobbying expenditure (in millions) | |||||
---|---|---|---|---|---|---|---|
Q1 2020 | Q4 2019 | Name | Segment | Q1 2020 | Q4 2019 | % change | COVID-19 |
1 | 1 | PhRMA | Pharmaceutical | $ 11.51 | $ 8.88 | 30% | $ 0.43 |
2 | 4 | American Medical Association | Professional services | $ 6.88 | $ 4.20 | 64% | $ 3.07 |
3 | 3 | American Hospital Association | Hospital | $ 6.31 | $ 6.99 | − 10% | $ 0.11 |
4 | 2 | Blue Cross Blue Shield Companies | Health insurance | $ 5.67 | $ 7.28 | − 22% | $ 1.43 |
5 | 7 | Pfizer Inc. | Pharmaceutical | $ 5.13 | $ 3.28 | 56% | $ 0.30 |
6 | 10 | Americas Health Insurance Plans | Health insurance | $ 4.05 | $ 2.75 | 47% | $ 2.22 |
7 | 8 | CVS Corporation | Pharmacy | $ 4.05 | $ 2.98 | 36% | $ 0.59 |
8 | 5 | Amgen Inc. | Pharmaceutical | $ 3.93 | $ 3.61 | 9% | $ 0.32 |
9 | 44 | Novartis International | Pharmaceutical | $ 3.76 | $ 1.05 | 259% | $ 0.58 |
10 | 13 | Genentech, Inc. | Pharmaceutical | $ 3.61 | $ 2.43 | 49% | $ 1.05 |
11 | 6 | Biotechnology Innovation Organization | Pharmaceutical | $ 3.38 | $ 3.56 | − 5% | $ 2.14 |
12 | 32 | AbbVie Inc. | Pharmaceutical | $ 3.32 | $ 1.30 | 155% | $ 0.03 |
13 | 16 | Gilead Sciences, Inc. | Pharmaceutical | $ 3.16 | $ 2.04 | 55% | $ 0.61 |
14 | 20 | Air Medical Group Holdings | Ambulance | $ 2.70 | $ 1.81 | 49% | $ - |
15 | 26 | Merck & Co., Inc. | Pharmaceutical | $ 2.70 | $ 1.55 | 74% | $ 0.60 |
16 | 22 | Aflac Inc. | Health insurance | $ 2.60 | $ 1.77 | 47% | $ - |
17 | 12 | Bayer Corporation | Pharmaceutical | $ 2.57 | $ 2.50 | 3% | $ 0.71 |
18 | 23 | GE Healthcare | Medical devices | $ 2.56 | $ 1.75 | 46% | $ 0.52 |
19 | 11 | AdvaMed | Medical devices | $ 2.13 | $ 2.63 | − 19% | $ 0.90 |
20 | 37 | Sanofi S.A. | Pharmaceutical | $ 2.12 | $ 1.20 | 77% | $ 0.35 |
21 | 17 | Johnson and Johnson | Medical devices | $ 2.03 | $ 1.94 | 5% | $ 0.38 |
22 | 25 | UnitedHealth Group Incorporated | Health insurance | $ 2.01 | $ 1.64 | 23% | $ 0.09 |
23 | 27 | Horizon Therapeutics PLC | Pharmaceutical | $ 1.82 | $ 1.49 | 22% | $ 0.84 |
24 | 19 | Fresenius Medical Care | Dialysis | $ 1.82 | $ 1.82 | 0% | $ 1.52 |
25 | 63 | AstraZeneca plc | Pharmaceutical | $ 1.80 | $ 0.71 | 154% | $ 0.67 |
26 | 47 | Davita Inc. | Dialysis | $ 1.75 | $ 0.99 | 77% | $ 1.13 |
27 | 14 | Eli Lilly and Company | Pharmaceutical | $ 1.66 | $ 2.18 | − 24% | $ 0.17 |
28 | 28 | Alkermes plc | Pharmaceutical | $ 1.54 | $ 1.44 | 7% | $ 0.04 |
29 | 128 | Biogen Inc. | Pharmaceutical | $ 1.51 | $ 0.34 | 344% | $ 0.39 |
30 | 46 | Walgreens Company | Pharmacy | $ 1.51 | $ 1.00 | 51% | $ 0.46 |
Total | $ 99.53 | $ 77.06 | 55%a | $ 21.64 |
PhRMA, Pharmaceutical Research and Manufacturers of America
a55% is the average of the percentages presented above